Sign In
Step 1
Unite with Fellow Investors
Step 2
Choose the Best Attorney
Step 3
Provide Documents
Step 4
Follow Case Progress
Step 5
Get Payout
CVS.US
id: 1287

CVS Health (CVS) Financial Misrepresentation Case

The defendant has requested the court to dismiss the case.
S.D. New York
Court
1:24-cv-05303
Case number
05/03/2023
Class period Start
04/30/2024
Class period End
09/10/2024
Lead Plaintiff motion deadline

  • $CVS stockholder filed a claim against CVS Health for overstating profits from its Health Care Benefits segment.

  • After disappointing financial results, $CVS fell by 2.73% on August 3, 2023.

  • CVS Health investors can join this case to be notified about potential recovery.

Case Details:

On August 2, 2023, CVS announced its quarterly results and lowered its expected earnings per share to $6.53-$6.75 from $6.90-$7.12.

On the same day, in a quarterly report to the SEC, CVS reported a 30.7% drop in operating income, down $1.4B, mainly due to declines in its Health Care Benefits segment.

On this news, $CVS fell by 2.73% on August 3, 2023.

Based on these events, a $CVS stockholder filed a claim against CVS Health and its leaders, accusing them of the following:

  • CVS's forecasts didn't account for rising medical costs and usage patterns.

  • This led to unexpected expenses, overstating the Health Care Benefits segment's profitability.

  • Other revenue streams couldn't offset the increased costs in the Health Care Benefits segment.

Considering all the representations, investors have reasons to suspect that CVS Health overstated profits from its Health Care Benefits segment.

Case Status
Motion to dismiss
Alleged Offence
Mismanagement, 
Misleading Statements, 
Omissions
Suspected Party
Directors, 
Management
Security Type
Stocks
Trade Direction
Long
Shock Event Date
08/03/2023
Filing date
07/12/2024
Lead Plaintiff Deadline
09/10/2024